Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan I So

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 31, 2022
UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imagingRoss J Mason, Karim Marzouk, Antonio Finelli, et al.
Cancer Research|June 19, 2008
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancerBoris A Hadaschik, Kaixin Zhang, Alan I So, et al.
BJU International|April 4, 2008
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancerBoris A Hadaschik, Melanie G ter Borg, John Jackson, et al.
NPJ Genomic Medicine|March 29, 2020
Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancerMegan E Tesch, Justin A Pater, Gillian Vandekerkhove, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 31, 2022
UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changesRoss J Mason, Karim Marzouk, Antonio Finelli, et al.
Molecular Cancer Therapeutics|February 7, 2015
Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell CarcinomaKyung Seok Han, Na Li, Peter A Raven, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 26, 2023
BeTTer Outcomes Workgroup Health Quality Initiative to optimize bone health for prostate cancer patients in the British Columbia Cancer SystemKrista Noonan, Jenny J Ko, Peter C Black, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 31, 2022
2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium: Meeting highlightsAnil Kapoor, Tamim Niazi, Krista Noonan, et al.
World Journal of Urology|August 29, 2019
Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculatorMiles P Mannas, Taeweon Lee, Connor M Forbes, et al.
BJU International|September 14, 2007
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imagingBoris A Hadaschik, Peter C Black, Jason C Sea, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 31, 2022
UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imagingRoss J Mason, Karim Marzouk, Antonio Finelli, et al.
Cancer Research|June 19, 2008
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancerBoris A Hadaschik, Kaixin Zhang, Alan I So, et al.
BJU International|April 4, 2008
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancerBoris A Hadaschik, Melanie G ter Borg, John Jackson, et al.
NPJ Genomic Medicine|March 29, 2020
Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancerMegan E Tesch, Justin A Pater, Gillian Vandekerkhove, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 31, 2022
UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changesRoss J Mason, Karim Marzouk, Antonio Finelli, et al.
Molecular Cancer Therapeutics|February 7, 2015
Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell CarcinomaKyung Seok Han, Na Li, Peter A Raven, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 26, 2023
BeTTer Outcomes Workgroup Health Quality Initiative to optimize bone health for prostate cancer patients in the British Columbia Cancer SystemKrista Noonan, Jenny J Ko, Peter C Black, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 31, 2022
2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium: Meeting highlightsAnil Kapoor, Tamim Niazi, Krista Noonan, et al.
World Journal of Urology|August 29, 2019
Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculatorMiles P Mannas, Taeweon Lee, Connor M Forbes, et al.
BJU International|September 14, 2007
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imagingBoris A Hadaschik, Peter C Black, Jason C Sea, et al.
Pageof 10